Facial Plast Surg 2011; 27(6): 523-528
DOI: 10.1055/s-0031-1298785
© Thieme Medical Publishers

Hyaluronic Acid Fillers: History and Overview

Ji-Eon Kim1 , Jonathan M. Sykes1
  • 1Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology–Head and Neck Surgery, University of California, Davis, Sacramento, California
Weitere Informationen


28. Dezember 2011 (online)


Hyaluronic acid (HA) fillers have many favorable characteristics that make it a popular injectable filler device. Its minimal immunogenicity and relative ease of use has helped HA become the most commonly used injectable filler today. A brief history of injectable fillers, the various injection techniques, and legal ramifications are discussed. A review of the most recent literature compares the efficacy and safety of HA to other injectable filler substances.


  • 1 Neuber F. Fat grafting.  Chir Kongr Verhandl Dtsch Ges Chir. 1893;  22 66
  • 2 Gersuny R. Ueber eine subcutyane Prosthese.  Z Heilk. 1900;  30 1-5
  • 3 U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Sulfanilamide Disaster. Available at: http://www.fda.gov/AboutFDA/WhatWeDo/History/ProductRegulation/SulfanilamideDisaster/default.htm Last accessed, December 15, 2011
  • 4 Matton G, Anseeuw A, De Keyser F. The history of injectable biomaterials and the biology of collagen.  Aesthetic Plast Surg. 1985;  9 133-140
  • 5 Paraffingranulome S. Munch Med Wochenschr. 1922;  69 215-220
  • 6 Orentreich D S, Orentreich N. Injectable fluid silicone. In: Roenigk R K, Roenigk Jr H H, eds. Dermatologic Surgery: Principles and Practice. New York: Marcel Dekker; 1989: 1349-1395
  • 7 Webster R C, Fuleihan N S, Gaunt J M et al.. Injectable silicone for small augmentations: twenty-year experience in humans.  Am J Cosm Surg. 1984;  1 1-7
  • 8 Landman M D, Strahan R W, Ward P H. Chin augmentation with polytef paste injection.  Arch Otolaryngol. 1972;  95 72-75
  • 9 Ashinoff R. Overview: soft tissue augmentation.  Clin Plast Surg. 2000;  27 479-487
  • 10 U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Approved wrinkle fillers. Available at: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/CosmeticDevices/WrinkleFillers/ucm227749.htm Last accessed, December 15, 2011
  • 11 Krauss M C. Recent advances in soft tissue augmentation.  Semin Cutan Med Surg. 1999;  18 119-128
  • 12 Duranti F, Salti G, Bovani B, Calandra M, Rosati M L. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study.  Dermatol Surg. 1998;  24 1317-1325
  • 13 Lowe N J, Maxwell C A, Lowe P, Duick M G, Shah K. Hyaluronic acid skin fillers: adverse reactions and skin testing.  J Am Acad Dermatol. 2001;  45 930-933
  • 14 Maas C S. Characteristics of implant materials.  Arch Facial Plast Surg. 2000;  2 67
  • 15 Micheels P. Human anti-hyaluronic acid antibodies: is it possible?.  Dermatol Surg. 2001;  27 185-191
  • 16 Fernández-Aceñero M J, Zamora E, Borbujo J. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation.  Dermatol Surg. 2003;  29 1225-1226
  • 17 Vartanian A J, Frankel A S, Rubin M G. Injected hyaluronidase reduces restylane-mediated cutaneous augmentation.  Arch Facial Plast Surg. 2005;  7 231-237
  • 18 Rohrich R J, Nguyen A T, Kenkel J M. Lexicon for soft tissue implants.  Dermatol Surg. 2009;  35 (Suppl 2) 1605-1611
  • 19 U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Restylane™ injectable gel - P020023. Available at: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm082242.htm Last accessed, December 15, 2011
  • 20 ASPS & ASAPS Advisory . Plast Reconstr Surg. 2006;  118 (Suppl 3) 129-132S
  • 21 Baumann L S, Shamban A T, Lupo M P JUVEDERM vs. ZYPLAST Nasolabial Fold Study Group et al. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study.  Dermatol Surg. 2007;  33 (Suppl 2) S128-S135
  • 22 Lupo M P, Smith S R, Thomas J A, Murphy D K, Beddingfield III F C. Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds.  Plast Reconstr Surg. 2008;  121 289-297
  • 23 Narins R S, Brandt F, Leyden J, Lorenc Z P, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds.  Dermatol Surg. 2003;  29 588-595
  • 24 Moers-Carpi M M, Vogt S, Santos B M, Planas J, Vallve S R, Howell D J. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds.  Dermatol Surg. 2007;  33 (Suppl 2) S144-S151
  • 25 Moers-Carpi M M, Tufet J O. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial.  Dermatol Surg. 2008;  34 210-215
  • 26 Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A.  Dermatol Surg. 2003;  29 802-809
  • 27 Onesti M, Toscani M, Curinga G, Chiummariello S, Scuderi N. Assessment of a new hyaluronic acid filler. Double-blind, randomized, comparative study between Puragen and Captique in the treatment of nasolabial folds.  In Vivo. 2009;  23 479-486
  • 28 Kono T, Kinney B M, Groff W F, Chan H H, Ercocen A R, Nozaki M. Randomized, evaluator-blind, split-face comparison study of single cross-linked versus double cross-linked hyaluronic acid in the treatment of glabellar lines.  Dermatol Surg. 2008;  34 (Suppl 1) S25-S30
  • 29 Glogau R G, Kane M A. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers.  Dermatol Surg. 2008;  34 (Suppl 1) S105-S109
  • 30 DeLorenzi C, Weinberg M, Solish N, Swift A. The long-term efficacy and safety of a subcutaneously injected large-particle stabilized hyaluronic acid-based gel of nonanimal origin in esthetic facial contouring.  Dermatol Surg. 2009;  35 (Suppl 1) 313-321
  • 31 Friedman P M, Mafong E A, Kauvar A N, Geronemus R G. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation.  Dermatol Surg. 2002;  28 491-494
  • 32 Grimes P E, Thomas J A, Murphy D K. Safety and effectiveness of hyaluronic acid fillers in skin of color.  J Cosmet Dermatol. 2009;  8 162-168

Jonathan M. SykesM.D. 

Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology–Head and Neck Surgery

2521 Stockton Blvd, Suite 6206, Sacramento, CA 95817

eMail: jonathan.sykes@ucdmc.ucdavis.edu